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We investigated the role of kainate (KA) receptor activa-
tion and desensitization in inducing the increase in the
intracellular free Ca21 concentration ([Ca21]i) in individual
cultured rat hippocampal neurons. The rat hippocampal
neurons in the cultures were shown to express kainate
receptor subunits, KA2 and GluR6/7, either by immuno-
cytochemistry or by immunoblot analysis. The effect of
LY303070, an a-amino-3-hydroxy-5-methyl-isoxazole-4-
propionate (AMPA) receptor antagonist, on the alter-
ations in the [Ca21]i caused by kainate showed cell-to-
cell variability. The [Ca21]i increase caused by kainate
was mostly mediated by the activation of AMPA recep-
tors because LY303070 inhibited the response to kainate
in a high percentage of neurons. The response to kainate
was potentiated by concanavalin A (Con A), which inhib-
its kainate receptor desensitization, in 82.1% of the
neurons, and this potentiation was not reversed by
LY303070 in about 38% of the neurons. Also, upon stim-
ulation of the cells with 4-methylglutamate (MGA), a se-
lective kainate receptor agonist, in the presence of Con
A, it was possible to observe [Ca21]i changes induced by
kainate receptor activation, because LY303070 did not
inhibit the response in all neurons analyzed. In toxicity
studies, cultured rat hippocampal neurons were exposed
to the drugs for 30 min, and the cell viability was evalu-
ated at 24 hr using the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay. The selective
activation of kainate receptors with MGA, in the presence
of Con A, induced a toxic effect, which was not pre-
vented by LY303070, revealing a contribution of a small
subpopulation of neurons expressing kainate receptors
that independently mediate cytotoxicity. Taken together,
these results indicate that cultured hippocampal neurons
express not only AMPA receptors, but also kainate re-
ceptors, which can modulate the [Ca21]i and toxicity. J.
Neurosci. Res. 65:378–386, 2001. © 2001 Wiley-Liss, Inc.
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Non-NMDA receptors have been extensively stud-
ied in the last years, but only more recently it was possible
to establish that kainate receptors exist as independent
receptors in neurons (Lerma, 1997). The cloning of glu-
tamate receptors (Hollmann and Heinemann, 1994) and
the discovery of new pharmacologic tools (Bleakman,
1999; Chittajallu et al., 1999) has allowed to better un-
derstand their physiological roles.
Several observations suggest that kainate receptors
play an important role in epilepsy and excitotoxicity (Pol-
lard et al., 1994; Mulle et al., 1998; Routbort et al., 1999;
Moldrich et al., 2000). Although some studies show that
kainate-induced toxicity is mainly due to the activation of
AMPA receptors (Ohno et al., 1997; Ferreira et al., 1998;
Ambro´sio et al., 2000), other reports also demonstrate the
presence of functional kainate receptors (Parternain et al.,
1995) and their involvement in excitotoxicity (Sa´nchez-
Go´mez and Matute, 1999). Selective agonists and antag-
onists to AMPA and kainate receptors have been used to
unmask the role of kainate receptors (Malva et al., 1995;
Savidge et al., 1997; Bleakman et al., 1998). Thus, GYKI
53655, a selective non-competitive AMPA receptor an-
tagonist, protects cultured neurons against AMPA toxicity
and minimally affects kainate-induced responses at kainate
receptors (Paternain et al., 1995; Kova´cs et al., 1997). Also,
experiments carried out using homomeric human GluR5
receptors have demonstrated that LY293558 and
LY294486 antagonize the actions of kainate in the CA3
area of the rat hippocampus (Vignes et al., 1997). The use
of a selective kainate receptor antagonist, LY382884, has
allowed to determine the involvement of these receptors
in synaptic plasticity in the mossy fiber projection of the
hippocampus (Bortolotto et al., 1999), although this con-
clusion has been challenged recently (Nicoll et al., 2000).
Many compounds that can interact with AMPA and
kainate receptors to reduce desensitization have also been
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identified (Partin et al., 1993). Cyclothiazide (CTZ),
which blocks AMPA receptor desensitization, enhanced
both AMPA and kainate excitotoxicity in rat hippocampal
neurons (Ohno et al., 1998; Ambro´sio et al., 2000), and
this effect was partially (24 hr exposure) or totally (30 min
exposure) prevented by LY303070, the (2)enantiomer of
GYKI 53655 (Ambro´sio et al., 2000). Concerning the
kainate receptor desensitization, concanavalin A (Con A),
a plant lectin, is a potent pharmacologic tool in inhibiting
the desensitization of kainate receptors (Partin et al.,
1993). In Con A-treated cerebellar granule cells, currents
evoked by low concentrations of kainate are not signifi-
cantly reduced by GYKI 53655 (Pemberton et al., 1998).
Also, the selective activation of kainate receptors, in the
presence of Con A, can result in neuronal toxicity in
cultured murine neocortical cells (Jensen et al., 1999).
The link between the [Ca21]i increase and cell death
has been demonstrated in studies that show that the acti-
vation of non-NMDA receptors can increase the intracel-
lular free Ca21 concentration ([Ca21]i) (Brorson et al.,
1994), which can in turn lead to a cascade of intracellular
events, and finally to cell death by necrosis or apoptosis
(Choi, 1985; McGinnis et al., 1999). Also, it has been
demonstrated that kainate- and AMPA-induced toxicity
in cortical neurons is greatly attenuated by omission of
external Ca21, and the increase in [Ca21]i is due to
stimulation of Ca21 influx rather than release from intra-
cellular stores (Frandsen et al., 1993).
We have determined previously the existence of
different populations of hippocampal neurons with differ-
ent AMPA receptors, in terms of AMPA receptor-
mediated [Ca21]i changes and subsequent toxicity (Am-
bro´sio et al., 2000). Because AMPA and kainate receptors
can coexist within a single cell as two independent entities
(Partin et al., 1993), in this study, we examined the role of
kainate receptors in the [Ca21]i increase, with particular
attention to the desensitization of kainate-preferring re-
ceptors, and also in the putative neurotoxicity in cultured
hippocampal neurons. A selective agonist of kainate re-
ceptors (MGA) (Jones et al., 1997; Donevau et al., 1998),
and a blocker of receptor desensitization (Con A) were
used to evaluate the contribution of kainate receptors to
[Ca21]i and toxicity. The role of active kainate receptors
in both [Ca21]i changes and excitotoxicity was also elu-
cidated by the direct identification of KA2 and GluR6/7
subunits of kainate receptors by using immunocytochem-
istry and Western immunoblotting techniques. Prelimi-
nary results of this work were published previously in
abstract form (Silva et al., 2000).
MATERIALS AND METHODS
Cell Culture
Hippocampal neurons were dissociated from hippocampi of
E18–E19 Wistar rat embryos (the mothers were killed by rapid
cervical dislocation), after treatment with trypsin (2.0 mg/ml,
15 min, 37°C) and deoxyribonuclease I (0.15 mg/ml) in Ca21- and
Mg21-free Hank’s balanced salt solution (137 mM NaCl, 5.36 mM
KCl, 0.44 mM KH2PO4, 0.34 mM Na2HPO42H2O, 4.16 mM
NaHCO3, 5 mM glucose, 1 mM sodium pyruvate, 10 mM
HEPES, pH 7.4). The cells were cultured in serum-free Neurobasal
medium, supplemented with B27 supplement, glutamate (25 mM),
glutamine (0.5 mM) and gentamicin (0.12 mg/ml), as described
previously (Brewer et al., 1993). Cultures were kept at 37°C in a
humidified incubator in 5% CO2/95% air, for 7–8 days, the time
required for maturation of hippocampal neurons.
For calcium imaging and immunocytochemistry studies,
cells were plated on poly-D-lysine-coated (0.1 mg/ml) glass
coverslips at a density of 45 3 103 cells/cm2. For the assessment
of neuronal injury with the MTT assay and for Western immu-
noblotting, cells were plated on poly-D-lysine-coated multiwells
at a density of 0.1 3 106 cells/cm2.
MAP-2 and Kainate Receptor Immunocytochemistry
Hippocampal neurons plated on coverslips at a density of
45 3103 cells/cm2 were washed twice with 0.15 M PBS, and
fixed with 4% paraformaldehyde for 30 min at 37°C. Coverslip-
mounted cells were then incubated with 0.2% Triton X-100 for
2 min at room temperature and non-specific binding subse-
quently blocked with 3% BSA for 30 min at room temperature.
Cells were then incubated for 1 hr at room temperature with
anti-mouse MAP-2 (1:500 dilution), and for double-
immunolabeling studies hippocampal neurons were incubated
with a mixture of both anti-mouse MAP-2 and anti-rabbit KA2
(1:100) or anti-mouse MAP-2 and anti-rabbit GluR6/7 (1:20).
Furthermore, incubation with secondary antibodies (1:100; anti-
mouse IgG for MAP-2; anti-rabbit IgG for KA2 and GluR6/7)
was conducted for 1 hr at room temperature. Finally, cells were
mounted using a Prolong Antifade Kit and after drying, the
neurons were visualized in a Confocal Fluorescence Micro-
scopic (Bio-Rad MRC 600, Cambridge, MA).
Western Immunoblotting Analysis
Hippocampal neurons plated on poly-D-lysine-coated
multiwells at a density of 0.1 3 106 cells/cm2 were washed in
PBS medium (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4,
1.8 mM KH2PO4, pH 7.4), and then collected with a cell
scraper in lysis medium (20 mM HEPES, 1 mM EDTA, pH 7.4)
supplemented with a cocktail of protease inhibitors (100 mM
phenylmethylsulfonyl fluoride, PMSF, 1 mM benzamidine,
50 mM leupeptin, 50 mM antipain and 1 mM pepstatin). After
sonication (6 3 5 sec with 2 sec on-off pulses), the cell suspen-
sion was centrifuged in a refrigerated Eppendorf microfuge
(3,500 rpm, for 2 min, followed by centrifugation of the super-
natant at 14,000 rpm, for 12 min). The final pellet was then
resuspended in PBS medium supplemented with the protease
inhibitors cocktail.
Various aliquots of equal amount of membrane protein
(10 mg) was loaded in a 4% running polyacrylamide gel and 7.5%
spacer gel, subjected to electrophoresis, and then transferred to
polyvinylidene (PVDF) membranes (Amersham, Arlington
Heights, IL ). Membranes were saturated with 5% (w/v) fat-free
dry milk in Tris-buffered saline (50 mM Tris, 150 mM NaCl,
pH 7.6) with 0.1% Tween 20 (TBS-T), for 1 hr 45 min at room
temperature. Blots were then further incubated for 2 hr, at room
temperature, with primary antibodies at 1:600 and 1:800 dilu-
tions for KA2 and GluR6/7, respectively. After washing with
1% milk TBS-T solution, blots were further incubated over-
night, at 4°C, with anti-rabbit IgG antibody coupled to alkaline
phosphatase. The immune complex was detected by the ECF
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System (Amersham) and visualized by scanning on a STORM
860 (Molecular Dynamics, Sunnyvale, CA), using blue excited
fluorescence.
Fura-2 Fluorescence Measurements by Video Imaging
Hippocampal neurons plated on coverslips at a density of
45 3 103 cells/cm2 were loaded by incubation with 5 mM
fura-2/AM and 0.02% Pluronic F-127 for 45 min, at 37°C, in
Krebs buffer supplemented with 0.1% BSA (w/v), essentially as
described previously (Ambro´sio et al., 2000). After incubation,
the coverslips were washed and placed in a perfusion chamber
on the stage of an inverted Nikon Diaphot fluorescence micro-
scope. The cells were then perfused with Krebs buffer (37°C) for
about 5 min before data acquisition. The experiments were
conducted under continuous superfusion with Krebs buffer con-
taining the drugs, as indicated in the figure legends. The neurons
were stimulated 15 sec after starting image acquisition, and when
required, preincubated with 250 mg/ml Con A for 5 min before
stimulation with the receptor agonists. Fluorescence changes
were recorded with a multiple excitation Magical imaging sys-
tem (Applied Imaging, UK). Hippocampal neurons were alter-
nately excited at 340 and 380 nm using a switching filter wheel,
and the emitted fluorescence, collected with a 403 objective
(Nikon, The Netherlands), was driven to a Photonics Science
SIT camera, after passing through a 510 nm bandpass filter.
Image analysis was carried out with the Magical system and
software developed by Dr. Enrique Castro (Faculty of Veteri-
nary Sciences, Complutense University of Madrid, Madrid,
Spain). The background fluorescence at each wavelength was
subtracted and fluorescence ratios calculated on a pixel-by-pixel
basis, being ratio data stored as an 8-bit pseudocolored images.
Areas of the cell bodies were drawn and the averaged value of
pixel intensities was evaluated at each time point, to obtain ratio
vs. time plots for all areas defined. The results were expressed as
the ratio of fluorescence intensity with excitation at 340 nm and
380 nm.
Assessment of Neuronal Injury
Assessment of neuronal injury was carried out by using the
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay. Krebs buffer with MTT (0.5 mg/ml) was added to
the cell cultures and incubated for 1 hr at 37°C in the incubation
chamber. MTT, when taken up by cells that remain alive, is
converted from yellow to a water-insoluble blue-colored prod-
uct (Mossman, 1983). The precipitated dye was dissolved in
0.04 M HCl in isopropanol, for 5 min, and colorimetrically
(absorbance at 570 nm) quantitated. All experiments were car-
ried out in triplicate.
Toxicity Experiments
Neurons cultured for 7 DIV were exposed to drugs for
30 min, and when using Con A, neurons were preincubated
with 250 mg/ml (in HEPES-buffered saline solution) for 5 min
at 37°C. Drug exposure for 30 min in conditioned medium was
carried out after removal of the Con A solution (Jensen et al.,
1999). Aliquots of 250 ml (conditioned medium) were taken
from each well, the drugs were added, and homogenized. Then,
the aliquots were again added to the correspondent well, and the
medium gently mixed to preserve the integrity of neurons. After
incubation with the drugs, cells were carefully washed two times
with Krebs buffer (132 mM NaCl, 4 mM KCl, 1.4 mM MgCl2,
1 mM CaCl2, 6 mM glucose, 10 mM HEPES-Na, pH 7.4), and
then further incubated for 24 hr in Neurobasal medium supple-
mented with B27 supplement (GIBCO BRL, Gaithersburg,
MD), glutamate (25 mM), glutamine (0.5 mM) and gentamicin
(0.12 mg/ml). In these experiments, Con A had effects on the
control values (MTT reduction was 68.6 6 2.1% of the con-
trol). Thus, the control conditions in all experiments with Con
A treatment were a 5 min preincubation with this lectin, fol-
lowed by the 30 min incubation with conditioned medium.
Chemicals
Neurobasal medium, B27 supplement, gentamicin and
trypsin (USP grade) were purchased from GIBCO BRL (Life
Technologies, Scotland, UK). Glutamate, DNase (DN-25),
MTT, concanavalin A (Con A), protease inhibitors and anti-
mouse MAP-2 were purchased from Sigma Chemical Company
(St. Louis, MO), Kainate (KA), cyclothiazide (CTZ) and
4-methylglutamate (MGA) were purchased from TOCRIS
(Ballwin, MO). LY 303070 was a kind gift of Lilly Research
Laboratories (Indianapolis, IN). The acetoxymethyl ester of
Fura-2 (Fura-2/AM) and Pluronic F-127 were purchased from
Molecular Probes (Leiden, The Netherlands). KA2 and
GluR6/7 antibodies were from Upstate Biotechnology Inc.,
(Lake Placid, NY). Goat anti-rabbit and anti-mouse IgG anti-
bodies, anti-alkaline phosphatase linked antibodies and ECF
substrate were purchased from Amersham (Buckinghamshire,
England). All the other reagents were from Sigma, or from
Merck-Schuchardt, Germany. LY 303070, CTZ, Fura-2/AM
and Pluronic F-127 stock solutions were prepared in DMSO.
Statistical Analysis
The data are expressed as means 6 SEM. Statistics were
carried out using an analysis of variance (ANOVA), followed by
Dunnett’s post-test, as indicated in the figure legends. In the
[Ca21]i measurements, due to the variability of the responses
among cells, the 95% Confidence Intervals (95% CI) are indi-
cated.
RESULTS
Expression of Kainate Receptor Subunits
Cell immunoreactivity with the neuronal marker
Microtubule Associated Protein 2 (MAP-2) (1:500) indi-
cated that ;95% of cells were neurons (Fig. 1A). The
labeling seen in the presence of anti-MAP-2 antibody was
localized all over the cell, but especially in the neurites
(Fig. 1A). These observations suggest that a nearly pure
neuronal population is obtained as glial growth is reduced
in the cultured hippocampal neurons utilized in the
present study (Brewer et al., 1993).
We could also identify the presence of kainate re-
ceptor subunits in the cultures by using either immuno-
cytochemistry or immunoblotting. KA2- (1:100) (Fig. 1B)
or GluR6/7-like (1:20) immunoreactivity (Fig. 1C) was
detected especially within the cell bodies, but also with
strong punctuate labeling in the neurites. Moreover,
double-labeling immunocytochemical studies suggest a
predominant localization of KA2 or GluR6/7 subunits at
synaptic sites in the cultured neurons. Furthermore, West-
380 Silva et al.
ern immunoblotting analysis of KA2 and GluR6/7 sub-
units in membranes isolated from cultured hippocampal
neurons identified a ;123 kDa and ;115 kDa band for
KA2 and GluR6/7, respectively (Fig. 2A,B). For compar-
ison, P2 membranes obtained from 6-week-old Wistar rat
hippocampus were analyzed by Western immunoblotting,
using the same antibodies, and we also identified the two
bands. In addition, in the case of anti GluR6/7 antibodies,
a band of ;99 kDa was also identified.
Kainate-Induced [Ca21]i Increase: Single Cell
Imaging of Hippocampal Neurons
A prolonged increase in intracellular Ca21 is re-
garded as one major trigger of the neurodegenerative
processes. To better understand the role of kainate recep-
tors in cell death, we analyzed [Ca21]i changes evoked by
different kainate receptor agonists, in individual cells in the
cultured neurons, and the results are illustrated in Figures
3–5. We observed that, when neurons were stimulated
with kainate at low concentrations (10 mM), 33% of
neurons did not show any response (49 neurons analyzed).
In a higher percentage of cells (67%), however, we could
observe an increase in the 340 nm/380 nm fluorescence
ratio. In the cells that respond to 10 mM kainate with an
increase in [Ca21]i, we determined the inhibitory effect of
LY303070 on kainate-induced responses, and three sub-
populations of neurons were detected. In the first, second,
and third population of cells, we considered neurons
where the kainate-evoked response in the presence of
LY303070 was between 10% and 50%, 50% and 90% or
90% and 110% of the control, respectively. In the first
population of cells (33% of neurons) (Fig. 3A) the response
to kainate was strongly inhibited to 33.7 6 2.2% of the
control (95% CI between 29.0 and 38.3%); in the second
population (26% of neurons) (Fig. 3B) the response to
kainate was moderately inhibited to 64.8 6 3.0% of the
control (95% CI between 58.6 and 71.1%); and in a third
small population of cells (8.2% of neurons) LY303070 did
not inhibit the response to kainate (101.0 6 3.0% of the
Fig. 1. Confocal image of cultured hippocampal cells labeled with (A)
anti-microtubule associated protein 2 antibody (MAP-2) (1:500 dilu-
tion) (red) or a mixture of both (B) anti-MAP-2 and anti-KA2 (1:100)
(green) or (C) anti-MAP-2 and anti-GluR6/7 (1:20) (green). The
white bar below the figure represent 25 mm. Note the strong positive
labeling of the MAP-2 antibody along the neurites and the KA2- or
GluR6/7-like punctuate immunoreactivity. The figures shown are
representative of the whole culture. The same pattern of labeling was
obtained for two independent cultures.
Fig. 2. Western blot analysis of kainate receptor subunits (A) KA2 and
(B) GluR6/7 in membranes of P2 fraction obtained from 6-week-old
Wistar rat hippocampus and in membranes isolated from cultured
hippocampal neurons. The immune complex was detected by the ECF
system and visualized by scanning on a STORM 860, using blue
excited fluorescence. Standard proteins were used as a molecular weight
markers (Broad Range; Bio-Rad Laboratories, Richmond), and the
molecular weight standards are indicated (kDa). Similar results were
obtained from two independent preparations.
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control) (95% CI between 93.4 and 108.7%) (not shown).
The [Ca21]i increase in the 340 nm/380 nm fluorescence
ratio in the cells of first (33% of neurons) (Fig. 3A) or
second population of cells (26% of neurons) (Fig. 3B) was
0.06 6 0.01 (95% CI between 0.05 and 0.07) or 0.07 6
0.01 (95% CI between 0.06 and 0.09), respectively, in
control conditions (first stimulus, without LY303070).
We then tested the effect of blocking desensitization
of kainate receptors on the [Ca21]i changes evoked by
kainate. We observed that the presence of Con A
(250 mg/ml) significantly enhanced the [Ca21]i changes
evoked by 10 mM kainate in 82.1% of neurons (196
neurons analyzed). The response was potentiated to
142.3 6 2.1% of the control (95% CI between 138.1 and
146.5%) in 70.9% of neurons, as illustrated in Figure 4A,
and to 245.2 6 11.4% in a smaller percentage of neurons
(11.2%) (95% CI between 221.5 and 268.9%) (not
shown). In the first group of cells, we considered the
response between 110% and 200% of the control, and
above this value, we considered the second group. The
increase in the fluorescence ratio in the cells from the first
(70.9% of neurons) (Fig. 4A) or second group (11.2% of
neurons) (not shown) was 0.17 6 0.01 (95% CI between
0.15 and 0.20) or 0.07 6 0.01 (95% CI between 0.05 and
0.08), respectively, in control conditions (first stimulus,
without Con A). Contrarily to what happened when
neurons were stimulated only with kainate, the presence
of Con A induced a kainate receptor response in a higher
percentage of neurons (82% versus 67% of neurons).
Moreover, two distinct populations were found based on
Fig. 3. Increase in the [Ca 21]i upon stimulation of hippocampal
neurons with 10 mM kainate. Representative recordings of two pop-
ulations of neurons showing a (A) strong (33% of neurons) or (B)
moderate inhibition (26% of neurons) of the [Ca21]i response in the
presence of 15 mM LY303070. Neurons were stimulated 15 sec after
data acquisition and each recording lasted 75 sec. The second recording
in each experiment was carried out 15 min after the end of the first. The
recordings are representative of data obtained from 49 cultured hip-
pocampal neurons (two independent cultures).
Fig. 4. Effect of non-desensitizing activation of kainate receptors on the [Ca21]i upon stimulation
with 10 mM kainate. (A) Potentiation of [Ca21]i response by Con A (250 mg/ml). (B) and (C) Two
populations of neurons showing (B) no effect of LY303070 (37.7% of neurons) or (C) a partial
inhibition (37.7% of neurons) on the [Ca21]i response. Each recording (A–C) is representative of one
of three subpopulations of neurons that responded differently in the presence of Con A. The results
were obtained from 196 neurons (four independent cultures).
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the inhibitory effect caused by LY303070. In the first
population (37.7% of neurons) (Fig. 4B), the response
induced by kainate in the presence of Con A was not
inhibited by LY303070. In the second population (37.7%
of neurons), LY303070 decreased the response to kainate
plus Con A as follows: in 10.1% of neurons the response
was greatly inhibited to 35.4 6 3.9% of the control, as
illustrated in Figure 4C (95% CI between 26.0 and
44.8%), whereas in 27.5% of total neurons, the response
was moderately inhibited to 69.4 6 2.8% of the control
(95% CI between 63.6 and 75.1%) (not shown). The
fluorescence ratio in the cells from the second group, in
control conditions (first stimulus, without Con A and
LY303070), was 0.31 6 0.05 (95% CI between 0.20 and
0.42) in 10.1 % of total neurons, and 0.15 6 0.02 (95% CI
between 0.11 and 0.19) in 27.5% of total neurons.
Concanavalin A Unmasks Active Kainate
Receptors Upon Stimulation With MGA
We also investigated the [Ca21]i alterations evoked
by MGA, because it has been shown that this compound
is a potent and selective agonist at kainate receptors, at least
for the low concentrations (10 mM) utilized (Jones et al.,
1997; Donevan et al., 1998). We analyzed 44 neurons in
the cultures, and in 86.4% of the cells, the response in-
duced by MGA (10 mM) was unmasked in the presence of
Con A (Fig. 5A). So, in the presence of this lectin, MGA
did mediate the [Ca21]i increase to 151.5 6 4.8% of the
control (95% CI between 141.7 and 161.2%) in 63.6% of
total neurons (not shown), and to 271.3 6 15.3% of the
control, in 22.7% of neurons (95% CI between 236.8 and
305.8%) (Fig. 5A). Moreover, LY303070 did not inhibit
the response to MGA plus Con A in all cells analyzed as
illustrated in Fig. 5B. The increase in the fluorescence
ratio in the first (63.6% of neurons) or second group
(22.7% of neurons) was 0.06 6 0.01 (95% CI between
0.05 and 0.10) or 0.04 6 0.01 (95% CI between 0.03 and
0.04), respectively, in control conditions (first stimulus,
without Con A). Thus, in these specific conditions of
stimulation (MGA plus Con A), we could observe a clear
role of kainate receptors in producing [Ca21]i changes in
hippocampal neurons, independent of AMPA receptor
contribution.
Neurotoxic Effect of MGA in the Presence of a
Kainate Receptor Desensitization Blocker in
Hippocampal Neurons
The selective kainate receptor agonist, 4-methyl-
glutamate (MGA; 10 mM), was without effect in inducing
cell death by itself (Fig. 6). When the cells were exposed
to MGA in the presence of Con A for 30 min, however,
we observed the unmasking of MGA toxicity, because the
MTT reduction was 75.5 6 3.2% of the control. Further-
more, this effect was not abolished by LY303070 (15 mM),
a non-competitive AMPA receptor antagonist (73.2 6
5.2% of control) (Fig. 6). In the presence of cyclothiazide
(CTZ; 30 mM), a blocker of AMPA receptor desensitiza-
tion, 10 mM MGA did not result in significant toxicity,
because the MTT reduction was 99.7 61.9% of the con-
trol, suggesting that in this case AMPA receptors were not
involved (Fig. 6). Thus, when using a selective agonist to
kainate receptors, and in the presence of a receptor desen-
sitization blocker, it was possible to unmask a consistent
toxic effect insensitive to AMPA receptor antagonist.
DISCUSSION
The present work shows that cultured hippocampal
neurons express functional kainate receptors that respond
with different sensitivities to kainate and to MGA, in the
presence of Con A. Moreover, the results also indicate that
kainate receptor desensitization play an important role in
kainate-induced increase in intracellular free Ca21.
The role of AMPA receptors desensitization on the
neuronal viability has been extensively studied recently
(Ohno et al., 1997; Ferreira at al., 1998; Ambro´sio et al.,
2000), but for several years the role of kainate receptors
remained elusive. The specific role of kainate receptors as
modulators of synaptic transmission has, however already
been revealed (Paternain et al., 1995; Jones et al., 1997;
Vignes and Collingridge, 1997; Wilding and Huetter,
1997; Malva et al., 1998). The pharmacologic differenti-
ation between active AMPA and kainate receptors was
possible due to the development of selective agonists to
kainate receptors (Wong et al., 1994; Donevan et al.,
1998; Swanson et al., 1998a) and selective AMPA receptor
antagonists (Bleakman et al., 1996). Some kainate receptor
Fig. 5. Challenging neurons with the
selective kainate receptor agonist MGA
(10 mM) resulted in the [Ca21]i increase,
only in the presence on Con A (250
mg/ml). (A) Effect of Con A (250 mg/
ml) on the [Ca21]i responses induced by
10 mM MGA. (B) Effect of LY 303070
(15 mM) on the [Ca21]i responses in-
duced by MGA in the presence of Con
A. The traces in A and B are represen-
tative of two populations of neurons in
terms of the [Ca21]i response in the
presence of Con A or Con A plus
LY303070, respectively. The results
were obtained from 44 neurons (two
independent cultures).
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agonists, like (5)-5-iodowillardiine (IW) (Swanson et al.,
1998a), (R,S)-2-amino-3-(3-hydroxy-5-tert-butylisoxazol-
4-yl)propanoic acid (ATPA) (Chittajallu et al., 1999; Jo-
hansen et al., 1999) and domoate (Malva et al., 1996; Larm
et al., 1997) are extensively used. Recent studies demon-
strate, however that (2S,4R)-4-methylglutamate (MGA) is
the most potent and selective agonist at kainate receptors
(Jones et al., 1997; Donevan et al., 1998), and that it has no
effect on AMPA-evoked inward currents in the presence
of cyclothiazide (CTZ) in cerebellar granule cells (Savidge
et al., 1999). Moreover, it has been shown that Ca21
influx and subsequent elevation of [Ca21]i is crucial in
triggering neuronal death after exposure to excitatory
amino acids (Choi, 1985).
In the present work, the pharmacologic identifica-
tion of kainate receptors in single cell Ca21 imaging
studies is evident. Kainate, even at low concentrations
(10 mM), was not a selective agonist for these receptors,
and the response could in part be mediated by active
AMPA receptors. The blockade of kainate receptor de-
sensitization by Con A, which is selective to these recep-
tors (Huettner, 1990; Partin et al., 1993) allowed, how-
ever, to unmask the role of kainate receptors on the
[Ca21]i changes. It was also very interesting to observe
that hippocampal neurons showed variability in terms of
the inhibitory effect caused by LY303070. In some cells
the [Ca21]i changes were only mediated by kainate recep-
tors and in others the response can be due to AMPA
receptors, or to both AMPA and kainate receptors in the
same cell. The variability of neuronal responses may be
due to the possibility that Con A action depends on the
receptor type (Yue et al., 1995; Everts et al., 1999; Lerma,
1999), different affinities to the agonist/antagonist or dif-
ferent expression levels of kainate and AMPA receptors.
Previous studies also showed that CTZ enhanced AMPA-
induced [Ca21]i responses with great variability (Hoyt et
al., 1995; Sekiguchi et al., 1998; Ambro´sio et al., 2000).
Moreover, it is well established that the desensitization
kinetics of kainate receptors depends of the subunit com-
position (Swanson et al., 1998b), and that brief exposure
to the lectin Con A eliminates desensitization of current
gated by kainate and domoate. Using the more selective
agonist to kainate receptors (MGA) (Jones et al., 1997;
Donevan et al., 1998), we observed that, in the presence of
Con A, to eliminate receptor desensitization, MGA did
mediate the [Ca21]i increase. Contrary to what happened
when cells were stimulated with kainate, the response
induced by MGA in the presence of Con A was never
inhibited by the AMPA receptor antagonist, LY303070,
which further supports the involvement of kainate recep-
tors.
Previous studies have demonstrated that excitotox-
icity induced by kainate stimulation is mediated by
AMPA- but not by kainate-preferring receptors in hip-
pocampal neurons and in amacrine-like neurons in culture
(Ohno et al., 1997; Ferreira et al., 1998; Ambro´sio et al.,
2000). Kainate receptors can, however, mediate selective
responses (Paternain et al., 1995), especially in the pres-
ence of Con A (Savidge et al., 1997; Jensen et al., 1998).
In fact, this plant lectin (Con A) has been used as a tool to
unmask the activity of kainate receptors (Partin et al.,
1993; Savidge et al., 1997; Jensen et al., 1999), but may
also induce neuronal death by itself (Kulkarni et al., 1998).
Using MGA as a selective agonist for kainate receptors, we
could observe a neurotoxic effect only in the presence of
Con A. These results suggest a possible role of kainate
receptors in neurotoxicity, because LY303070 did not
protect neurons from the neurotoxic effect. Furthermore,
MGA in the presence of CTZ, which blocks AMPA
receptor desensitization (May and Robison, 1993), did not
induce toxicity, further excluding the contribution of
AMPA receptors. Concerning this toxic effect, however,
we suggest that a subpopulation of neurons that express
kainate receptors, may be susceptible to kainate receptor
cytotoxicity in the cultured hippocampal neurons.
We have also demonstrated that kainate receptor
subunits are present in the cultured hippocampal neurons.
Immunocytochemistry with antibodies against KA2 and
GluR6/7 subunits showed a high level of expression of
kainate receptors throughout the neuronal population.
Moreover, the same antibodies produced immunoreactive
bands with apparent molecular weights of 123 and 115
kDa, which are similar to the expected bands of KA2 and
Fig. 6. Effect of exposure of cultured hippocampal neurons to the
selective kainate receptor agonist, 4-methylglutamate (MGA). Neurons
were treated with 10 mM MGA in the presence of cyclothiazide (CTZ;
30 mM) for 30 min, or preincubated with Con A (250 mg/ml) (5 min)
and subsequently incubated with MGA (10 mM) for 30 min. The
results are presented as percentage of MTT reduction in control con-
ditions (no drug treatment or Con A alone), and represent the mean 6
SEM of at least four independent experiments carried out in triplicate.
**P . 0.01, significantly different from control (Con A pretreatment);
Dunnett’s post-test.
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GluR6/7 subunits (Herb et al., 1992; Raymond et al.,
1993; Roche et al., 1994). Thus, hippocampal cultures
express functional kainate receptors, which may play a role
in the excitotoxicity accordingly to previous observations
in GluR6 knockout mice (Mulle et al., 1998). These
results are also in agreement with some studies where an
increase in [Ca21]i was found to be mediated through
kainate-preferring receptors in cerebellar granule cells
(Savidge et al., 1997), and also with the finding that
activation of these receptors may cause oligodendroglial
cell death (Saˆnchez-Go´mez and Matute, 1999). We are
currently investigating the coupling mechanisms between
Ca21 influx after kainate receptor activation and neuro-
toxicity.
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